- Home
- PW vs JAGX Comparison
PW vs JAGX Comparison
Compare PW & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PW
- JAGX
- Stock Information
- Founded
- PW 1967
- JAGX 2013
- Country
- PW United States
- JAGX United States
- Employees
- PW N/A
- JAGX N/A
- Industry
- PW Real Estate Investment Trusts
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- PW Real Estate
- JAGX Health Care
- Exchange
- PW Nasdaq
- JAGX Nasdaq
- Market Cap
- PW 3.3M
- JAGX 3.9M
- IPO Year
- PW N/A
- JAGX N/A
- Fundamental
- Price
- PW $1.03
- JAGX $1.95
- Analyst Decision
- PW
- JAGX Strong Buy
- Analyst Count
- PW 0
- JAGX 1
- Target Price
- PW N/A
- JAGX $60.00
- AVG Volume (30 Days)
- PW 161.5K
- JAGX 153.9K
- Earning Date
- PW 10-30-2025
- JAGX 08-14-2025
- Dividend Yield
- PW N/A
- JAGX N/A
- EPS Growth
- PW N/A
- JAGX N/A
- EPS
- PW N/A
- JAGX N/A
- Revenue
- PW $2,988,491.00
- JAGX $11,810,000.00
- Revenue This Year
- PW N/A
- JAGX $22.41
- Revenue Next Year
- PW N/A
- JAGX $30.00
- P/E Ratio
- PW N/A
- JAGX N/A
- Revenue Growth
- PW 45.51
- JAGX 15.96
- 52 Week Low
- PW $0.63
- JAGX $1.57
- 52 Week High
- PW $2.75
- JAGX $35.25
- Technical
- Relative Strength Index (RSI)
- PW 43.21
- JAGX 48.05
- Support Level
- PW $0.91
- JAGX $1.60
- Resistance Level
- PW $1.06
- JAGX $2.16
- Average True Range (ATR)
- PW 0.17
- JAGX 0.12
- MACD
- PW -0.03
- JAGX 0.06
- Stochastic Oscillator
- PW 19.30
- JAGX 62.24
About PW Power REIT (MD)
Power REIT is an internally managed real estate investment trust (REIT) that owns a portfolio of real estate assets related to transportation, energy infrastructure, and Controlled Environment Agriculture (CEA) in the United States. Its investment portfolio comprises solar farm lands, railroad real estate, and various Controlled Environment Agriculture properties in the form of greenhouses for the cultivation of food and cannabis. In addition, the company is focused on opportunities in the form of investing in distressed situations, including debt and other types of secured interests in real estate, distressed properties, and real estate-related companies.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.